Osage Venture Partners News
May 2013
Pneuron, an outstanding enterprise data infrastructure solution
April 2013
Identropy Introduces “IDaaS For Dummies(R)” Book
Orange Accountable Care Partners with Halfpenny Technologies to help integrate their Care Community
BA Insight Closes Latest Round of Venture Funding
March 2013
Spooked by LinkedIn? This Guy Hails Goal-Scoring Machine
PeopleLinx Announces $3.2 Million In Series A Funding
PhillyInc: InstaMed looking like the picture of health
Vess Bakalov’s SevOne: Making Big Data Manageable
SAFEGUARD SCIENTIFICS LEADS $6 MILLION SERIES B FINANCING FOR PNEURON
UK system integrator to use FieldView DCIM in client data centers
February 2013
The 5 Pillars of DCIM – Improving Data Center Efficiencies
January 2013
Canvas featured in Verizon Wireless ad
Osage Venture Partners Exceeds Fundraising Target Closes Fund III with 66M
Top 5 Data Center Issues – DCIM to the Rescue
SevOne To Go For IPO, Raises $150 Million From Bain Capital to Expand P2P IT Monitoring
December 2012
Lowering Data Center Energy Bills: DCIM to the Rescue
November 2012
Identropy’s Identity-as-a-Service (IDaaS) Offering Now Manages Over One Million Users
DCIM and Co-Location: A Roadmap for Success
Ben Franklin Venture Idol coming to Lehigh University Nov. 15
October 2012
InstaMed Named a 2012 Philadelphia 100 Winner
Halfpenny Technologies Selected for 2012 Philadelphia 100 List of Fastest Growing Companies
BA Insight now global standard for enterprise search for DLA Piper
InstaMed Is First Company to Achieve EHNAC Healthcare and Financial Accreditations
September 2012
Halfpenny Technologies Announces Stage 2 Meaningful Use Tool Kit
Halfpenny Technologies Announces Expanded Offering for Health Plans
July 2012
June 2012
CEPTARIS SECURES $10 MILLION IN SERIES D-1 FINANCING
May 2012
English Skills a Concern as Global Aviation Grows
Carnegie Speech Appoints New CEO and Closes 3.4M Series B Round of Funding
April 2012
Pennsylvania Venture Firms Put Early-Stage Money Into NJ
February 2012
Ceptaris SECURES secures $15 million in venture debt financing
Halfpenny Technologies Secures $2.25 Million in Capital Investment
January 2012
Ceptaris Therapeutics Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel
LEARN MORE ABOUT OSAGE